SynCardia Total Artificial Heart Availbe With SynHall ValvesArtificial Heart Valves

SynCardia Systems Inc. now controls last key component in heart manufacturing

 

August 11, 2014
SynCardia Total Artificial Heart SynHall Valves FDA approval
SynCardia Systems Inc. received FDA approval to manufacture the SynCardia Total Artificial Heart with SynHall valves. The OK gives the company control over the two critical components for heart manufacturing: The valves and the unique formula for segmented polyurethane solution (SPUS), which is manufactured only by SynCardia.

SynCardia SynHall valves, use in the SynCardia Heart, are of the same design, materials and nearly identical manufacturing processes as the tilting-disk valves that have always been used in the Total Artificial Heart. Made of titanium and pyrolytic carbon, these robust valves have never failed in more than 1,300 implants of the SynCardia Total Artificial Heart, accounting for more than 5,000 valves and more than 30 years of use.

For more information: www.syncardia.com